Michael Hauptmann

Prof. Dr. Michael Hauptmann

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Cancer Cell
Verified
Journal Article
Closed access
KBKatrien Berns
Katrien Berns
HHHugo M. Horlings
Hugo M. Horlings
BHBryan T. Hennessy
Bryan T. Hennessy
MMMandy Madiredjo
Mandy Madiredjo
EHE. Marielle Hijmans
E. Marielle Hijmans
RBRené Bernards
René Bernards

14 July 2008 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
BWB Weigelt
B Weigelt
HHHm Horlings
Hm Horlings
BKB Kreike
B Kreike
MHMm Hayes
Mm Hayes
MHMichael Hauptmann
Michael Hauptmann
JPJl Peterse
Jl Peterse

20 January 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
FNFrederika A. van Nimwegen
Frederika A. van Nimwegen
MSMichael Schaapveld
Michael Schaapveld
DCDavid J. Cutter
David J. Cutter
CJCècile P.M. Janus
Cècile P.M. Janus
AKAugustinus D.G. Krol
Augustinus D.G. Krol
FLFlora E. van Leeuwen
Flora E. van Leeuwen
Purpose: Cardiovascular diseases are increasingly recognized as late effects of Hodgkin lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for coronary heart disease (CHD) and to quantify the effects of radiation dose to the heart, chemotherapy, and other cardiovascular risk factors. Patients and Methods: We conducted a nested case-control study in a cohort of 2,617 5-year HL survivors, treated between 1965 and 1995. Cases were patients diagnosed with CHD as their first cardiovascular event after HL. Detailed treatment information was collected from medical records of 325 cases and 1,204 matched controls. Radiation charts and simulation radiographs were used to estimate in-field heart volume and mean heart dose (MHD). A risk factor questionnaire was sent to patients still alive. Results: The median interval between HL and CHD was 19.0 years. Risk of CHD increased linearly with increasing MHD (excess relative risk [ERR]) per Gray, 7.4%; 95% CI, 3.3% to 14.8%). This results in a 2.5-fold increased risk of CHD for patients receiving a MHD of 20 Gy from mediastinal radiotherapy, compared with patients not treated with mediastinal radiotherapy. ERRs seemed to decrease with each tertile of age at treatment (ERR/Gy<27.5years, 20.0%; ERR/Gy27.5-36.4years, 8.8%; ERR/Gy36.5-50.9years, 4.2%; Pinteraction = .149). Having ≥ 1 classic CHD risk factor (diabetes mellitus, hypertension, or hypercholesterolemia) independently increased CHD risk (rate ratio, 1.5; 95% CI, 1.1 to 2.1). A high level of physical activity was associated with decreased CHD risk (rate ratio, 0.5; 95% CI, 0.3 to 0.8). Conclusion: The linear radiation dose-response relationship identified can be used to predict CHD risk for future HL patients and survivors. Appropriate early management of CHD risk factors and stimulation of physical activity may reduce CHD risk in HL survivors.

9 November 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MBMagda Bosch de Basea
Magda Bosch de Basea
ITIsabelle Thierry-Chef
Isabelle Thierry-Chef
RHRichard Harbron
Richard Harbron
MHMichael Hauptmann
Michael Hauptmann
GBGraham Byrnes
Graham Byrnes
ECElisabeth Cardis
Elisabeth Cardis
Over one million European children undergo computed tomography (CT) scans annually. Although moderate- to high-dose ionizing radiation exposure is an established risk factor for hematological malignancies, risks at CT examination dose levels remain uncertain. Here we followed up a multinational cohort (EPI-CT) of 948,174 individuals who underwent CT examinations before age 22 years in nine European countries. Radiation doses to the active bone marrow were estimated on the basis of body part scanned, patient characteristics, time period and inferred CT technical parameters. We found an association between cumulative dose and risk of all hematological malignancies, with an excess relative risk of 1.96 (95% confidence interval 1.10 to 3.12) per 100 mGy (790 cases). Similar estimates were obtained for lymphoid and myeloid malignancies. Results suggest that for every 10,000 children examined today (mean dose 8 mGy), 1–2 persons are expected to develop a hematological malignancy attributable to radiation exposure in the subsequent 12 years. Our results strengthen the body of evidence of increased cancer risk at low radiation doses and highlight the need for continued justification of pediatric CT examinations and optimization of doses.

15 July 2008 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
Gabriel ChodickGabriel Chodick
Gabriel Chodick
NBNural Bekiroglu
Nural Bekiroglu
MHMichael Hauptmann
Michael Hauptmann
BABruce H. Alexander
Bruce H. Alexander
DFD. Michal Freedman
D. Michal Freedman
ASAlice J. Sigurdson
Alice J. Sigurdson
The study aim was to determine the risk of cataract among radiologic technologists with respect to occupational and nonoccupational exposures to ionizing radiation and to personal characteristics. A prospective cohort of 35,705 cataract-free US radiologic technologists aged 24–44 years was followed for nearly 20 years (1983–2004) by using two follow-up questionnaires. During the study period, 2,382 cataracts and 647 cataract extractions were reported. Cigarette smoking for ≥5 pack-years; body mass index of ≥25 kg/m2; and history of diabetes, hypertension, hypercholesterolemia, or arthritis at baseline were significantly (p ≤ 0.05) associated with increased risk of cataract. In multivariate models, self-report of ≥3 x-rays to the face/neck was associated with a hazard ratio of cataract of 1.25 (95% confidence interval: 1.06, 1.47). For workers in the highest category (mean, 60 mGy) versus lowest category (mean, 5 mGy) of occupational dose to the lens of the eye, the adjusted hazard ratio of cataract was 1.18 (95% confidence interval: 0.99, 1.40). Findings challenge the National Council on Radiation Protection and International Commission on Radiological Protection assumptions that the lowest cumulative ionizing radiation dose to the lens of the eye that can produce a progressive cataract is approximately 2 Gy, and they support the hypothesis that the lowest cataractogenic dose in humans is substantially less than previously thought.

18 July 2018 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
PDF file
JMJohanna M Meulepas
Johanna M Meulepas
CRCécile M Ronckers
Cécile M Ronckers
ASAnne M J B Smets
Anne M J B Smets
RNRutger A J Nievelstein
Rutger A J Nievelstein
PGPatrycja Gradowska
Patrycja Gradowska
MHMichael Hauptmann
Michael Hauptmann
Computed tomography (CT), a strong diagnostic tool, delivers higher radiation doses than most imaging modalities. As CT use has increased rapidly, radiation protection is important, particularly among children. We evaluate leukemia and brain tumor risk following exposure to low-dose ionizing radiation from CT scans in childhood. For a nationwide retrospective cohort of 168 394 children who received one or more CT scans in a Dutch hospital between 1979 and 2012 who were younger than age 18 years, we obtained cancer incidence, vital status, and confounder information by record linkage with external registries. Standardized incidence ratios were calculated using cancer incidence rates from the general Dutch population. Excess relative risks (ERRs) per 100 mGy organ dose were calculated with Poisson regression. All statistical tests were two-sided. Standardized incidence ratios were elevated for all cancer sites. Mean cumulative bone marrow doses were 9.5 mGy at the end of follow-up, and leukemia risk (excluding myelodysplastic syndrome) was not associated with cumulative bone marrow dose (44 cases). Cumulative brain dose was on average 38.5 mGy and was statistically significantly associated with risk for malignant and nonmalignant brain tumors combined (ERR/100 mGy: 0.86, 95% confidence interval = 0.20 to 2.22, P = .002, 84 cases). Excluding tuberous sclerosis complex patients did not substantially change the risk. We found evidence that CT-related radiation exposure increases brain tumor risk. No association was observed for leukemia. Compared with the general population, incidence of brain tumors was higher in the cohort of children with CT scans, requiring cautious interpretation of the findings.